1396 related articles for article (PubMed ID: 17560755)
1. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
Binhas M; Krakowski I; Marty J
Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. [Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation].
Rostaing-Rigattieri S; Rousselot H; Krakowski I; Theobald S; Collin E; Vuillemin N; Balp L; Torloting G; Fergane B; Richard B; Duclos R; Eschalier A; Delorme T; Minello C; Toussaint S; Richard A; Magnet M; Chvetzoff G; Larue F; Navez ML; Collard O; Bonnefoi MP; Couturier M; Santolaria N; Wagner JP; Fabre N
Bull Cancer; 2003; 90(8-9):795-806. PubMed ID: 14609771
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of pain in cancer with systemically administered opioids].
Enting RH; van der Rijt CC; Wilms EB; Lieverse PJ; de Wit R; Smitt PA
Ned Tijdschr Geneeskd; 2001 May; 145(20):950-4. PubMed ID: 11396259
[TBL] [Abstract][Full Text] [Related]
5. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
6. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
8. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
10. [Transdermal route as an alternative to oral administration of opioids in cancer pain].
Burza M; Ginobbi P; Fusco G; Laurenzi L; Tirelli W; Arcuri E
Clin Ter; 1998; 149(4):277-80. PubMed ID: 9866889
[TBL] [Abstract][Full Text] [Related]
11. [Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002)].
Krakowski I; Theobald S; Balp L; Bonnefoi MP; Chvetzoff G; Collard O; Collin E; Couturier M; Delorme T; Duclos R; Eschalier A; Ffergane B; Larue F; Magnet M; Minello C; Navez ML; Richard A; Richard B; Rostaing-Rigattieri S; Rousselot H;
Bull Cancer; 2002 Dec; 89(12):1067-74. PubMed ID: 12525366
[TBL] [Abstract][Full Text] [Related]
12. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
[TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine in cancer pain and palliative care.
Sittl R
Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
[TBL] [Abstract][Full Text] [Related]
14. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
[TBL] [Abstract][Full Text] [Related]
16. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
[TBL] [Abstract][Full Text] [Related]
17. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
Pergolizzi JV; Mercadante S; Echaburu AV; Van den Eynden B; Fragoso RM; Mordarski S; Lybaert W; Beniak J; Orońska A; Slama O;
Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402
[TBL] [Abstract][Full Text] [Related]
18. [Basic studies on cancer pain control].
Yajima Y; Narita M; Ozaki M; Niikura K; Suzuki T
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1377-83. PubMed ID: 16227733
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects and treatment of pain in children and adolescents with cancer.
Monteiro Caran EM; Dias CG; Seber A; Petrilli AS
Pediatr Blood Cancer; 2005 Dec; 45(7):925-32. PubMed ID: 16106427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]